Viewing Study NCT02339168


Ignite Creation Date: 2025-12-24 @ 5:33 PM
Ignite Modification Date: 2026-04-21 @ 9:56 PM
Study NCT ID: NCT02339168
Status: COMPLETED
Last Update Posted: 2025-05-01
First Post: 2015-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer
Sponsor: University of California, Davis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module